| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 7.9% | $8,279,228 | 4,058,445 | Point72 Asset Management, L.P. | 17 Feb 2026 | |||
| Chernett Jorey | 9.5% | +21% | $11,824,823 | +$2,541,903 | 3,802,194 | +27% | Chernett Jorey | 31 Dec 2025 |
| Fonda Laura Natalia Monica | 5% | $3,856,902 | 1,928,451 | LAURA NATALIA MONICA FONDA | 22 Jul 2025 | |||
| Dauntless Investment Group, LLC | 1.2% | -85% | $1,466,437 | -$6,066,133 | 471,523 | -81% | Dauntless Investment Group, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 10 institutional investors reported holding 665,294 shares of OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO). This represents 1.3% of the company’s total 51,372,722 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 665,294 | $1,147,535 | -$2,989,322 | $2.07 | 10 |
| 2025 Q3 | 2,570,815 | $5,141,930 | -$400,030 | $2.00 | 8 |
| 2025 Q2 | 2,770,797 | $1,479,794 | +$329,427 | $2.57 | 5 |
| 2025 Q1 | 2,075,082 | $2,634,954 | +$1,447,536 | $1.27 | 7 |
| 2024 Q4 | 1,026,179 | $1,179,953 | +$28,548 | $1.15 | 7 |
| 2024 Q3 | 1,001,353 | $1,021,431 | -$19,942 | $1.03 | 6 |
| 2024 Q2 | 1,010,912 | $1,210,177 | +$115,592 | $1.20 | 7 |
| 2024 Q1 | 913,582 | $1,363,796 | +$79,673 | $1.50 | 6 |
| 2023 Q4 | 855,098 | $1,513,021 | +$1,343,703 | $1.77 | 7 |
| 2023 Q3 | 95,254 | $175,728 | +$153,652 | $1.85 | 7 |
| 2023 Q2 | 11,933 | $13,669 | +$13,669 | $1.15 | 1 |